Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.canlet.2020.01.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Retraction notice to "Corrigendum to 'Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer' [International Journal of Biological Macromolecules 248 (2023) 125782]".
Int J Biol Macromol
January 2025
Institute of Biomedical Sciences, College of Medicine, National Sun Yat-sen University, Kaohsiung 80424, Taiwan; Department of Mechanical and Electro-Mechanical Engineering, National Sun Yat-sen University, Kaohsiung 80424, Taiwan.
Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation.
Front Immunol
December 2024
The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
[This corrects the article DOI: 10.3389/fimmu.2023.
View Article and Find Full Text PDFCorrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.
Front Pharmacol
December 2024
Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States.
[This corrects the article DOI: 10.3389/fphar.2022.
View Article and Find Full Text PDFCorrigendum to "Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates" [Journal of Controlled Release 359 (2023) 175-187].
J Control Release
December 2024
Key Laboratory of Functional Polymer Materials of Ministry of Education, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!